BMC Research Notes

Table 3 Safety parameters

From: Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients

	Actual value
	n	Mean		SD
Serum iron, μg/dL	Week 0	54	60.1	33.5
	Week 8	33	82.1	23.5
	Week 16	33	80.2	29.0
Serum ferritin, ng/mL	Week 0	54	29.7	22.8
	Week 8	33	51.4	44.0
	Week 16	33	90.6	79.5
TSAT^a, %	Week 0	54	19.2	11.7
	Week 8	33	29.3	9.5
	Week 16	33	30.7	11.3
hs-CRP^b, ng/mL	Week 0	54	2801.6	4134.1
hs-CRP^b, ng/mL	Week 16	32	5980.6	16,191.3

^aTransferrin saturations
^bHigh-sensitivity C-reactive protein

Back to article page

ISSN: 1756-0500

Contact us

Submission enquiries: bmcresearchnotes@biomedcentral.com
General enquiries: ORSupport@springernature.com